Location · Minnesota
Clinical trials recruiting in Minnesota
563 recruiting studies have at least one site in Minnesota; 223 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Minnesota.
563 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
AbbVie
- Location
- Minneapolis, MN + 11 other US sites
- Eligibility basics
- Ages 5–17
- Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Kaneka Medical America LLC
- Location
- Minneapolis, MN + 9 other US sites
- Eligibility basics
- Up to age 21
- RecruitingPhase 2
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Cytokinetics
- Location
- Rochester, MN + 23 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
R1 Therapeutics
- Location
- Edina, MN + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Madrigal Pharmaceuticals, Inc.
- Location
- Rochester, MN + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Harmony Biosciences Management, Inc.
- Location
- Rochester, MN + 18 other US sites
- Eligibility basics
- Ages 6+
- RecruitingPhase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences GmbH
- Location
- Rochester, MN + 54 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Relay Therapeutics, Inc.
- Location
- Rochester, MN + 21 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
AbbVie
- Location
- Rochester, MN + 10 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Minneapolis, MN + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
Kodiak Sciences Inc
- Location
- Saint Louis Park, MN + 8 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
SPIRE Therapeutics Inc.
- Location
- Minneapolis, MN + 7 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Minneapolis, MN + 111 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
NGGT INC.
- Location
- Minneapolis, MN + 4 other US sites
- Eligibility basics
- Ages 18–55
- Recruiting
xDot Access Management System Early Feasibility Study
xDot Medical, Inc
- Location
- Saint Cloud, MN + 4 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
VDyne, Inc.
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Minneapolis, MN + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Rochester, MN + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Claris Biotherapeutics, Inc.
- Location
- Minnetonka, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
DeepQure Inc.
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 22–80
- RecruitingPhase 3
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Mankato, MN + 12 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Novartis Pharmaceuticals
- Location
- Minneapolis, MN + 4 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 1/Phase 2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Nkarta, Inc.
- Location
- Minneapolis, MN + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
Nuevocor Pte. Ltd.
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18+